Article title

Abstract

Keywords

Introduction

The role of NOX1 and NOX2 oxidases in the pharmacological correction of endothelial dysfunction

The role of ACE2 in the pharmacological correction of endothelial dysfunction

Arginase II is a promising target for the creation of drugs aimed at the pharmacological correction of endothelium-associated pathology

The possible role of the regulatory enzyme GSNO reductase (GSNOR) in the pharmacological correction of endothelial dysfunction

Conclusion

Conflicts of Interest

References

Contribution of authors